nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Chemical Biology as a Driver of Innovation in Cancer Research and Drug Discovery
|
Kostic, Milka |
|
2017 |
24 |
9 |
p. 1057- 1 p. |
artikel |
2 |
Drug Discovery and Chemical Biology of Cancer Epigenetics
|
Ribich, Scott |
|
2017 |
24 |
9 |
p. 1120-1147 28 p. |
artikel |
3 |
Emerging Opportunities for Target Discovery in Rare Cancers
|
Sharifnia, Tanaz |
|
2017 |
24 |
9 |
p. 1075-1091 17 p. |
artikel |
4 |
Joining Forces: The Chemical Biology–Medicinal Chemistry Continuum
|
Plowright, Alleyn T. |
|
2017 |
24 |
9 |
p. 1058-1065 8 p. |
artikel |
5 |
Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy
|
Hengel, Sarah R. |
|
2017 |
24 |
9 |
p. 1101-1119 19 p. |
artikel |
6 |
Small-Molecule Targets in Immuno-Oncology
|
Dhanak, Dashyant |
|
2017 |
24 |
9 |
p. 1148-1160 13 p. |
artikel |
7 |
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
|
Cromm, Philipp M. |
|
2017 |
24 |
9 |
p. 1181-1190 10 p. |
artikel |
8 |
Targeting Metabolism for Cancer Therapy
|
Luengo, Alba |
|
2017 |
24 |
9 |
p. 1161-1180 20 p. |
artikel |
9 |
The Pursuit of Therapeutic Biomarkers with High-Throughput Cancer Cell Drug Screens
|
Williams, Steven P. |
|
2017 |
24 |
9 |
p. 1066-1074 9 p. |
artikel |
10 |
Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery
|
Weeber, Fleur |
|
2017 |
24 |
9 |
p. 1092-1100 9 p. |
artikel |